News

Tarsus Pharmaceuticals Plans Engagement in Investor Conferences

Tarsus Pharmaceuticals Plans Engagement in Investor Conferences

Tarsus Pharmaceuticals Engages with Investors

Tarsus Pharmaceuticals, Inc. is gearing up for an exciting period of investor engagement. As part of its mission to further the field of eye care, the company has outlined its participation in two key events designed to provide insights into its progress and potential innovations. These conferences represent a valuable opportunity for investors to learn more about Tarsus and its initiatives.

Upcoming Investor Conferences

The first event, the Wells Fargo 20th Annual Healthcare Conference, is scheduled for September. Tarsus executives will share important updates and answer questions, aiming to build connections with potential investors.

Wells Fargo 20th Annual Healthcare Conference

This conference serves as a premier gathering for healthcare professionals and investors, providing a platform for Tarsus to showcase its advancements. Attendees can expect engaging discussions about the future of eye care and how Tarsus aims to address significant medical needs.

H.C. Wainwright 27th Annual Global Investment Conference

Following the Wells Fargo event, Tarsus will also participate in the H.C. Wainwright 27th Annual Global Investment Conference. This gathering will focus on innovative healthcare solutions, where Tarsus aims to present its ongoing research and how its products can make a difference in patients' lives.

Live Updates and Webcasts

For those interested in following along, Tarsus will provide live webcasts of these events. This ensures that regardless of location, interested parties can stay informed on the latest updates from Tarsus. Additionally, recorded sessions will be available on Tarsus’ website shortly after the events, making it easy for potential investors to access valuable insights at their convenience.

About Tarsus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. is at the forefront of innovating treatment solutions, particularly within eye care. The company leverages scientific research and technological advancements to develop therapeutic options that meet significant medical needs, including diseases that have historically been under-addressed.

Innovation in Eye Care

One of Tarsus’ significant achievements includes obtaining FDA approval for XDEMVY (lotilaner ophthalmic solution) 0.25%, aimed at treating Demodex blepharitis. Beyond this, Tarsus is in the process of expanding its pipeline with exciting developments such as TP-04, an ophthalmic gel intended for treating Ocular Rosacea, and TP-05, which is being studied as an oral tablet for Lyme disease prevention.

Staying Connected with Investors

Tarsus understands the importance of maintaining open lines of communication with its investors. The company's leadership is committed to transparency and regular updates regarding its clinical trials and product development, ensuring that stakeholders are well-informed as progress continues.

Contact Information

For media inquiries or to connect with investor relations, Tarsus Pharmaceuticals encourages reaching out directly. Media contact is provided by Adrienne Kemp, Sr. Director of Corporate Communications, at (949) 922-0801. For investor inquiries, David Nakasone, Head of Investor Relations, can be contacted at (949) 620-3223.

Frequently Asked Questions

What are the upcoming conferences Tarsus will participate in?

Tarsus will be present at the Wells Fargo 20th Annual Healthcare Conference and the H.C. Wainwright 27th Annual Global Investment Conference.

How can I access the webcasts of Tarsus' presentations?

Live webcasts will be available on Tarsus’ website, with recordings accessible afterward.

What is the significance of Tarsus' FDA-approved product?

XDEMVY is aimed at treating Demodex blepharitis, showcasing Tarsus' commitment to addressing unmet medical needs in eye care.

Who can I contact for media inquiries at Tarsus?

Adrienne Kemp serves as the media contact and can be reached at (949) 922-0801.

What investor relations initiatives does Tarsus undertake?

Tarsus actively engages with investors, providing updates and opportunities for interaction to keep them informed of the company's advancements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 9

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 5

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 10

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading

Top 5 Most Recently Viewed Articles

PermRock Royalty Trust Announces Latest Monthly Distribution

Updated Category News Views 305

PermRock Royalty Trust Declares Monthly Cash Distribution PermRock Royalty Trust (NYSE: PRT) has officially announced a monthly cash distribution for its trust unit holders, showcasing a commitment to returning value to investors. This distribution is part of the Trust's ongoing efforts to manage its financial obligations effectively and maintain a steady flow of cash to...

Continue Reading
Revolutionizing Cannabis Processing with the Osprey System

Updated Category News Views 277

The Evolution of Cannabis Processing The cannabis industry is changing rapidly, leading to a growing demand for high-quality, solventless products. To meet this demand without sacrificing quality, businesses require efficient processing methods. This is where innovative solutions like the Osprey hash washing machine come into play, offering a transformative option for...

Continue Reading
Unusual Options Activity Signals Insight for Merck & Co Investors

Updated Category News Views 98

Analyzing Recent Options Activity for Merck & Co In the world of finance, unusual options activity can often reveal insights into market trends. Recently, there’s been a noticeable shift, with investors adopting a bearish outlook on Merck & Co (MRK), prompting curiosity among retail traders. A significant increase in noteworthy trades has been captured through publicly...

Continue Reading
Discover Exciting Acting Opportunities in the Film Industry

Updated Category News Views 294

Find Your Next Acting Role in the Spotlight In a vibrant hub like Los Angeles, opportunities for actors continue to thrive, with Casting Networks leading the charge in connecting talent to exciting roles. Recently, a remarkable selection of casting calls has been released, showcasing a variety of projects eager for diverse talents. Exciting Casting Opportunities for...

Continue Reading
Nathan's Famous Delivers Strong Q1 Performance in 2025

Updated Category News Views 115

Nathan's Famous Reports Positive First Quarter Results Nathan's Famous, Inc. (NASDAQ: NATH) has unveiled its financial performance for the first fiscal quarter, which concluded on June 29, 2025. The company's results indicate a robust growth trajectory despite facing some challenges during this period. Financial Highlights from the Quarter The results from this...

Continue Reading